IntellaTriage

Bronchial carcinoma: Added benefit of crizotinib for first-line treatment not proven

Bronchial carcinoma: Added benefit of crizotinib for first-line treatment not proven

Control arm of the only study was no adequate representation of the appropriate comparator therapy.
Source: Medical News Today

© 2017 IntellaTriage